30 March 2020
The coronavirus pandemic has brought about far-reaching and wide-ranging health, social and economic consequences. Apart from confirmed cases and fatalities globally, the Covid-19 crisis brings with it unprecedented challenges for businesses in the current global environment.
In this uncertain economic climate, businesses may be legitimately considering collaboration or strategic transactions to manage disruptions in supply and demand, rationalise resources and combine strengths. In this vein, this article sets out some guidance on positioning and navigating any exposure to potential antitrust risks in Singapore, and more broadly, South-east Asia, for the immediate future, arising from such business collaborations. This article focuses on four main categories of industry collaborations, i.e. information exchanges, joint purchasing or sales agreements, cooperation on R&D and joint ventures.
To read more, please click here.
In addition, we have a cross-disciplinary Covid-19 Legal Task Force consisting of Partners across various practice areas to provide rapid assistance. Should you have any queries, please do not hesitate to get in touch with us at email@example.com.